Company
Invitae
Bringing the future of genetic testing within reach
Also known as Invitae Corporation
- Status
- Acquiredas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B2C
- Customers
- patients and their providers
- Legal name
- Invitae Corporation
- invitae.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Invitae is a leading medical genetics company, delivering genetic testing services and combining genetic and clinical information to power better health care decisions and drive medical research, improving the quality of healthcare for billions of people worldwide.
Funding snapshot
- Total raised
- $203MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $19.7M2020-04-01
Funding rounds
- Round, 2020
- $19.7M2020-04-01, SEC form D sold, 5 investors
- Round, 2020
- $52.4M2020-04-01, SEC form D sold, 58 investors
- Round, 2017
- $16.1M2017-08-04, SEC form D sold, 12 investors
- Round, 2017
- $73.5M2017-08-03, SEC form D sold, 23 investors
- Round, 2017
- $6M2017-06-11, SEC form D sold, 22 investors
- Round, 2012
- $29.6M2012-08-08, SEC form D sold, 16 investors
- Round, 2011
- $2.3M2011-03-16, SEC form D sold, 1 investor
- Round, 2010
- $3.6M2010-09-02, SEC form D sold, 10 investors
About the company
- Status notes
- Now that Invitae is a part of Labcorp
Loading relationship preview